Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Assets (2018 - 2025)

Historic Current Assets for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2025 value amounting to $3.2 billion.

  • Dr Reddys Laboratories' Current Assets rose 814.54% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 814.54%. This contributed to the annual value of $2.9 billion for FY2025, which is 161.29% down from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Current Assets stood at $3.2 billion, which was up 814.54% from $2.9 billion recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Current Assets ranged from a high of $3.2 billion in Q3 2025 and a low of $2.0 billion during Q1 2021
  • Over the past 5 years, Dr Reddys Laboratories' median Current Assets value was $2.6 billion (recorded in 2023), while the average stood at $2.6 billion.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Current Assets surged by 2156.21% in 2021, and later crashed by 330.08% in 2025.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Current Assets stood at $2.2 billion in 2021, then dropped by 0.04% to $2.2 billion in 2022, then grew by 19.56% to $2.6 billion in 2023, then increased by 12.49% to $3.0 billion in 2024, then increased by 8.15% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q3 2025, $2.9 billion for Q1 2025, and $3.0 billion during Q3 2024.